---
title: "TRex Bio hits 52-week low"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303765787.md"
description: "TRex Bio fell 2.88% to US$13.13. Down 6.28% over ten sessions and down 6.21% from first-day open."
datetime: "2026-10-30T14:09:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303765787.md)
  - [en](https://longbridge.com/en/news/303765787.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303765787.md)
generator: "portal-rs"
---

# TRex Bio hits 52-week low

TRex Bio (TRXB.US) fell nearly **3%** during regular trading to **$13.13**, hitting a 52-week low intraday.

The stock is down 6.28% over the past ten sessions and down 6.21% from its first-day open. It sits 20.71% below its 52-week high of US$16.56.

The Nasdaq Composite is down 1.36% over the past five sessions and up 10.16% year to date.

The company recently announced the completion of its initial public offering.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [TRXB.US](https://longbridge.com/en/quote/TRXB.US.md)

## Related News & Research

- [TRXB’s TRB-061 Drives Analyst Confidence as the $20 Price Target Remains Unchanged](https://longbridge.com/en/news/305821317.md)
- [Major Investor Makes Bold New Move into TRex Bio Stock](https://longbridge.com/en/news/301782322.md)
- [Marvell Stock’s (MRVL) Plunge Is My Opportunity to Buy](https://longbridge.com/en/news/306273400.md)
- [Gold Stocks Fall: What's Going On?](https://longbridge.com/en/news/306159306.md)
- [ANALYSIS-Anthropic listing extends Nasdaq's dominant run against arch-rival NYSE](https://longbridge.com/en/news/306184666.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**